• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Genetic Inhibition of Receptor Interacting Protein Kinase-1 Reduces Cell Death and Improves Functional Outcome After Intracerebral Hemorrhage in Mice Basic Sciences
Conclusions—The data show that the kinase domain of RIPK1 is a disease driver of ICH, mediating both acute cell death and functional outcome, and support development of RIPK1 inhibitors as therapeutic agents for human ICH.
Source: Stroke - August 28, 2017 Category: Neurology Authors: Sevda Lule, Limin Wu, Lauren M. McAllister, William J. Edmiston III, Joon Yong Chung, Emily Levy, Yi Zheng, Peter J. Gough, John Bertin, Alexei Degterev, Eng H. Lo, Michael J. Whalen Tags: Basic Science Research, Genetically Altered and Transgenic Models, Intracranial Hemorrhage Original Contributions Source Type: research

Sustained Neurological Recovery After Stroke in Aged Rats Treated With a Novel Prostacyclin Analog Basic Sciences
Conclusions—Our data suggest that targeting the IP receptor with MRE-269 is a novel strategy to reduce cerebral ischemia injury and promote long-term neurological recovery in ischemic stroke.
Source: Stroke - June 26, 2017 Category: Neurology Authors: Changjun Yang, Kelly M. DeMars, Jon C. Alexander, Marcelo Febo, Eduardo Candelario-Jalil Tags: Cerebrovascular Disease/Stroke, Ischemic Stroke, Neuroprotectants Original Contributions Source Type: research

Catabolic Signaling and Muscle Wasting After Acute Ischemic Stroke in Mice: Indication for a Stroke-Specific Sarcopenia Basic Sciences
Conclusions— Catabolic pathways of muscle tissue are activated after stroke. Impaired feeding, sympathetic overactivation, or infection cannot fully explain this catabolic activation. Wasting of the target muscle of the disrupted innervation correlated to severity of brain injury. Our data indicate the presence of a stroke-specific sarcopenia.
Source: Stroke - November 24, 2014 Category: Neurology Authors: Springer, J., Schust, S., Peske, K., Tschirner, A., Rex, A., Engel, O., Scherbakov, N., Meisel, A., von Haehling, S., Boschmann, M., Anker, S. D., Dirnagl, U., Doehner, W. Tags: Animal models of human disease, Other Stroke Treatment - Medical Basic Sciences Source Type: research

Inhibition of Transforming Growth Factor-{beta} Attenuates Brain Injury and Neurological Deficits in a Rat Model of Germinal Matrix Hemorrhage Basic Sciences
Conclusions— Increased level of TGF-β1 and activation of the TGF-β pathway associate with the development of brain injury after GMH. SD208 inhibits GMH-induced activation of the TGF-β pathway and leads to an improved developmental profile, partial recovery of cognitive and motor functions, and attenuation of GMH-induced brain atrophy and hydrocephalus.
Source: Stroke - February 24, 2014 Category: Neurology Authors: Manaenko, A., Lekic, T., Barnhart, M., Hartman, R., Zhang, J. H. Tags: Animal models of human disease, Neuroprotectors Basic Sciences Source Type: research